25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression

<div>25-OH vitamin D3 (ng mL<sup>−1</sup>) serum level in melanoma patients for individuals with normal and high LDH serum levels (U L<sup>−1</sup>). Prevalence depicts the subgroups of melanoma patients with high serum LDH congregating in the low serum 25-OH vitamin D3 ranges.</div>

Mediators of Inflammation

fig4

Figure 4

Figure 4: 25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and Progression 